Applications of transcriptomics in support of drug development for osteoarthritis
Objective: Understanding the heterogeneity and pathophysiology of osteoarthritis (OA) is critical to support the development of tailored disease-modifying treatments. To this aim, transcriptomics tools are highly relevant to delineate dysregulated molecular pathways and identify new therapeutic targ...
Enregistré dans:
Auteurs principaux: | Hélène Kaplon, Luo Yufei, Frédéric De Ceuninck, Agnès Lalande, Sophie Courtade-Gaiani, Laurence Laigle, Philippe Moingeon |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Elsevier
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4cf2075a13b540a8a40b0a21dab2775b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Molecular signaling in temporomandibular joint osteoarthritis
par: Ke Lu, et autres
Publié: (2022) -
Comorbidity of Fibromyalgia in Primary Knee Osteoarthritis: Potential Impact on Functional Status and Quality of Life
par: Mahgoub MY, et autres
Publié: (2020) -
Association between hypertension and osteoarthritis: A systematic review and meta-analysis of observational studies
par: Kenneth Lo, et autres
Publié: (2022) -
Comorbidity of Fibromyalgia in Primary Knee Osteoarthritis: Potential Impact on Functional Status and Quality of Life [Corrigendum]
par: Mahgoub MY, et autres
Publié: (2020) -
Anxiety and depression in patients with osteoarthritis: impact and management challenges
par: Sharma A, et autres
Publié: (2016)